Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs

Journal of Virological Methods

Volumn 85, Issue 1-2, 2000, Pages 203-214

  Zheng, Zhi Ming ^a   Baker, Carl C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gene expression; Papillomaviruses; RNA splicing; Tumor viruses

Indexed keywords

CELL EXTRACT; COBALT; EDETIC ACID; MAGNESIUM; MANGANESE; METAL ION;

ARTICLE; DROSOPHILA; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; ONCOVIRINAE; PAPILLOMA VIRUS; PRIORITY JOURNAL; RNA SEQUENCE; RNA SPLICING;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CATTLE; CELL EXTRACTS; COBALT; DNA-BINDING PROTEINS; DROSOPHILA; DROSOPHILA PROTEINS; EDETIC ACID; HELA CELLS; HUMANS; INSECT PROTEINS; MAGNESIUM; MANGANESE; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER; RNA, VIRAL;

BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; PAPILLOMAVIRUS; TUMOR VIRUS;

EID: 0033956415     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(99)00172-X     Document Type: Article

References (27)

1. Amendt B.A., Hesslein D., Chang L.-J., Stoltzfus C.M. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell Biol. 14:1994;3960-3970.
2. Amendt B.A., Si Z.-H., Stoltzfus C.M. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell Biol. 15:1995;4606-4615.
3. Barksdale S.K., Baker C.C. Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J. Virol. 69:1995;6553-6556.
4. Beliveau A., Leclerc S., Rouleau M., Guérin S.L. Multiple cloning sites from mammalian expression vectors interfere with gene promoter studies in vitro. Eur. J. Biochem. 261:1999;585-590.
5. Berget S.M., Moore C., Sharp P.A. Spliced segments at the 5′ terminus of adenovirus 2 late mRNA. Proc. Natl. Acad. Sci. USA. 74:1977;3171-3175.
6. Chow L.T., Gelinas R.E., Broker T.R., Roberts R.J. An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell. 12:1977;1-8.
7. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
8. Fu X.D. The superfamily of arginine/serine-rich splicing factors. RNA. 1:1995;663-680.
9. Grabowski P.J., Seiler S.R., Sharp P.A. A multicomponent complex is involved in the splicing of messenger RNA precursors. Cell. 42:1985;345-353.
10. Hardy S.F., Grabowski P.J., Padgett R.A., Sharp P.A. Cofactor requirements of splicing of purified messenger RNA precursors. Nature. 308:1984;375-377.
11. Hernandez N., Keller W. Splicing of in vitro synthesized messenger RNA precursors in HeLa cell extracts. Cell. 35:1983;89-99.
12. Howley P.M. Papillomavirinae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P. et al. Fields Virology. 1996;2045-2076 Lippincott-Raven, Philadelphia.
13. Jamison S.F., Crow A., Garcia-Blanco M.A. The spliceosome assembly pathway in mammalian extracts. Mol. Cell Biol. 12:1992;4279-4287.
14. Konarska M.M., Sharp P.A. Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs. Cell. 46:1986;845-855.
15. Krainer A.R., Maniatis T., Ruskin B., Green M.R. Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell. 36:1984;993-1005.
16. Manley J.L., Tacke R. SR proteins and splicing control. Genes Dev. 10:1996;1569-1579.
17. Milligan J.F., Groebe D.R., Witherell G.W., Uhlenbeck O.C. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15:1987;8783-8798.
18. Moore M.J., Query C.C., Sharp P.A. Splicing of precursors to messenger RNAs by the spliceosome. Gestland R.F., Atkins J.F. The RNA World. 1993;303-357 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Padgett R.A., Grabowski P.J., Konarska M.M., Seiler S., Sharp P.A. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55:1986;1119-1150.
20. Shah K.V., Howley P.M. Papillomaviruses. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P. Fields Virology. 1996;2077-2109 Lippincott-Raven, Philadelphia.
21. Sontheimer E.J., Sun S.G., Piccirilli J.A. Metal ion catalysis during splicing of premessenger RNA. Nature. 388:1997;801-805.
22. Steitz T.A., Steitz J.A. A general two-metal-ion mechanism for catalytic RNA. Proc. Natl. Acad. Sci. USA. 90:1993;6498-6502.
23. Umen J.G., Guthrie C. The second catalytic step of pre-mRNA splicing. RNA. 1:1995;869-885.
24. Zheng Z.M., He P., Baker C.C. Selection of the bovine papillomavirus type 1 nucleotide 3225 3′ splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J. Virol. 70:1996;4691-4699.
25. Zheng Z.M., He P.J., Baker C.C. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers. J. Virol. 71:1997;9096-9107.
26. Zheng Z.M., He P.J., Baker C.C. Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3′ splice site. J. Virol. 73:1999;29-36.
27. Zheng Z.M., Huynen M., Baker C.C. A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. Proc. Natl. Acad. Sci. USA. 95:1998;14088-14093.